Over the past 12 months, 8 insiders at Opus Genetics, Inc. filed 13 open-market SEC Form 4 transactions on IRD: 2 purchases worth $324K and 11 sales worth $16.3M. Insiders have been net sellers over this period. The most recent filing was on Jul 23, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 23, 26 | Robert E. GagnonChief Financial Officer | SELL | 7.8K | $2.95 | $23K |
| Jul 23, 26 | George MagrathChief Executive Officer, Director | SELL | 9.5K | $2.95 | $28K |
| Jul 23, 26 | Joseph K SchachleChief Operating Officer | SELL | 4.6K | $2.94 | $14K |
| Jul 23, 26 | Benjamin R YerxaPresident, Director | SELL | 7.4K | $2.97 | $22K |
| May 18, 26 | Foundation Fighting Blindness Retinal Degeneration Fund | SELL | 1.70M | $4.35 | $7.4M |
| Apr 23, 26 | Robert E. GagnonChief Financial Officer | SELL | 7.8K | $5.18 | $41K |
| Mar 16, 26 | Ashwath JayagopalChief Scientific & Dev. Ofc. | SELL | 3.7K | $5.12 | $19K |
| Mar 16, 26 | George MagrathChief Executive Officer | SELL | 24.4K | $5.21 | $127K |
| Mar 16, 26 | Joseph K SchachleChief Operating Officer | SELL | 3.7K | $5.25 | $20K |
| Mar 16, 26 | Rabourn Amy ZarembaHead of Fin. Quality Assurance | SELL | 2.8K | $5.25 | $15K |
| Dec 29, 25 | Cam GallagherDirector | BUY | 83.0K | $1.98 | $164K |
| Dec 9, 25 | Foundation Fighting Blindness Retinal Degeneration FundDirector,Other | SELL | 4.00M | $2.15 | $8.6M |
| Dec 26, 24 | George MagrathChief Executive Officer | BUY | 100.0K | $0.98 | $98K |
| Nov 21, 24 | Benjamin R YerxaPresident | BUY | 10.0K | $0.98 | $10K |
| Nov 18, 24 | George MagrathChief Executive Officer | BUY | 9.7K | $1.02 | $10K |
| Nov 15, 24 | George MagrathChief Executive Officer | BUY | 90.3K | $1.01 | $91K |
Over the past 12 months, insiders at Opus Genetics, Inc. filed 2 open-market purchases worth $324K and 11 sales worth $16.3M on IRD, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 23, 26.
The largest recent open-market IRD insider purchase in our data was $164K by Cam Gallagher, Director, filed on Dec 29, 25.
8 different insiders at Opus Genetics, Inc. filed open-market SEC Form 4 transactions on IRD over the last 12 months.
InsiderTape plots every IRD insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Opus Genetics, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →